why choose us

First received: August 27, 2024

Clinical Trial: Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Tract Infections

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety, Tolerability and Pharmacokinetics of Single Doses of GSK3923868 Administered Via Dry Powder Inhaler to Heal

Brief Summary: This study is designed to understand how the drug GSK3923868 works in the bodies of healthy people from Japanese, Chinese, and European ancestries.This is important to meet the rules for including these groups in future worldwide studies.The study is carefully planned to reduce differences that might come from comparing results across different studies and locations, making it easier to compare results between these ethnic groups.The main goal is to check if GSK3923868 is safe and easy to tolerate when given as a…

Read more